Nanobiotix SA - ADRNBTX
13F holders, Q2 2024 (June 30)12holders
1new positions
1sold out
$5.00avg. 13F price*
At the end of Q2 2024, 12 institutions reported holding Nanobiotix SA - ADR (NBTX) in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 1 sold out. The largest holders were Johnson & Johnson ($28.1M), Baillie Gifford & Co. ($14.3M) and Perceptive Advisors LLC ($2.8M).
- Company
- Nanobiotix SA - ADR
- CUSIP
- 63009J107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $550 |
| Exits | 1 | $3K |
All 13F filers, Q1 2024 → Q2 2024: 1,717 shares bought and 15,172 shares sold, net −13,455 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Johnson & Johnson | 7.02% | No change | 5,623,816 | $28.1M |
| Baillie Gifford & Co. | 0.01% | No change | 2,869,030 | $14.3M |
| Perceptive Advisors LLC | 0.07% | No change | 555,066 | $2.8M |
| BlackRock Inc. | 0.00% | Reduce -5.7% | 239,008 | $1.2M |
| UBS Group AG | 0.00% | No change | 3,100 | $16K |
| GAMMA Investing LLC | 0.00% | Add +76.5% | 2,030 | $10K |
| Bank of America Corp. | 0.00% | Add +190.1% | 760 | $4K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -44.6% | 343 | $2K |
| Royal Bank of Canada | 0.00% | Add +673.5% | 263 | $1K |
| Barclays PLC | 0.00% | New | 110 | $550 |
| Rhumbline Advisers | 0.00% | No change | 33 | $165 |
| Morgan Stanley | 0.00% | No change | 2 | $10 |
"% of holder's portfolio" is NBTX's weight in each manager's 13F, not the share of Nanobiotix SA - ADR the manager owns.